Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 817 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Radioligand Therapies (RLT) Director, Ecosystem Lead – Southern CA Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Jan 13, 2026 |
| Director, Oncology Priority Accounts - Nashville Regular, Full time | Development | USA +Alternative Locations | Field Non-Sales (USA) | Jan 13, 2026 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Pennsylvania Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Jan 13, 2026 |
| Program/Project Manager Regular, Full time | Marketing | Mexico | INSURGENTES | Jan 13, 2026 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Chicago Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Jan 13, 2026 |
| Elektriker/Elektrotechniker – HVAC Messstellenwartung (m/w/d), Schaftenau, Tirol, Österreich Regular, Part time | Production / Manufacturing | Austria | Kundl | Jan 13, 2026 |
| Analyst- Data Science Regular, Full time | Marketing | India | Hyderabad (Office) | Jan 13, 2026 |
| Market Access Manager (80-100%*) (temp role 12 months) Temporal (duración determinada), Full time | Strategic Planning & BD&L | Switzerland | Rotkreuz (Office-Based) | Jan 13, 2026 |
| Market Access Manager (80-100%*) (temp role 12 months) CDD (durée déterminée), Full time | Strategic Planning & BD&L | Switzerland | Rotkreuz (Office-Based) | Jan 13, 2026 |
| Market Access Manager (80-100%*) (temp role 12 months) Temporaneo (tempo determinato), Full time | Strategic Planning & BD&L | Switzerland | Rotkreuz (Office-Based) | Jan 13, 2026 |
Pagination
- ‹ Previous page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- …
- 82
- › Next page
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى